Frankfurt - Delayed Quote EUR
Corcept Therapeutics Incorporated (HTD.F)
68.78
+1.18
+(1.75%)
At close: 9:48:34 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
685,446
675,040
482,375
401,858
365,978
Cost of Revenue
10,750
10,882
6,481
5,385
5,281
Gross Profit
674,696
664,158
475,894
396,473
360,697
Operating Expense
563,829
527,207
368,612
283,839
236,220
Operating Income
110,867
136,951
107,282
112,634
124,477
Net Non Operating Interest Income Expense
25,251
24,542
17,275
3,557
529
Pretax Income
136,118
161,493
124,557
116,191
125,006
Tax Provision
2,124
20,284
18,417
14,773
12,494
Net Income Common Stockholders
132,507
139,733
105,496
101,288
112,512
Diluted NI Available to Com Stockholders
132,507
139,733
105,496
101,288
112,512
Basic EPS
1.27
1.35
1.02
0.95
0.97
Diluted EPS
1.15
1.23
0.94
0.87
0.89
Basic Average Shares
103,560.75
103,232
103,560
106,787
115,653
Diluted Average Shares
115,956
113,480
111,742
115,966
125,963
Total Operating Income as Reported
110,867
136,951
107,282
112,634
124,477
Total Expenses
574,579
538,089
375,093
289,224
241,501
Net Income from Continuing & Discontinued Operation
133,994
141,209
106,140
101,418
112,512
Normalized Income
133,994
141,209
106,140
101,418
112,512
Interest Income
25,251
24,542
17,275
3,557
529
Net Interest Income
25,251
24,542
17,275
3,557
529
EBIT
110,867
136,951
107,282
112,634
124,477
EBITDA
112,486
138,287
109,644
116,080
127,953
Reconciled Cost of Revenue
10,750
10,882
6,481
5,385
5,281
Reconciled Depreciation
1,619
1,336
2,362
3,446
3,476
Net Income from Continuing Operation Net Minority Interest
133,994
141,209
106,140
101,418
112,512
Total Unusual Items Excluding Goodwill
0
0
0
0
0
Total Unusual Items
0
0
0
0
0
Normalized EBITDA
112,486
138,287
109,644
116,080
127,953
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/15/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade